598 related articles for article (PubMed ID: 21811909)
1. The development of non-peptide glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes.
Moon HS; Kim MK; Son MH
Arch Pharm Res; 2011 Jul; 34(7):1041-3. PubMed ID: 21811909
[TBL] [Abstract][Full Text] [Related]
2. Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.
Vergès B; Bonnard C; Renard E
Diabetes Metab; 2011 Dec; 37(6):477-88. PubMed ID: 21871831
[TBL] [Abstract][Full Text] [Related]
3. Incretins: a new treatment option for type 2 diabetes?
Geelhoed-Duijvestijn PH
Neth J Med; 2007 Feb; 65(2):60-4. PubMed ID: 17379930
[TBL] [Abstract][Full Text] [Related]
4. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.
van Genugten RE; van Raalte DH; Diamant M
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S26-34. PubMed ID: 20115929
[TBL] [Abstract][Full Text] [Related]
5. Incretin-based therapy for type 2 diabetes mellitus: pancreatic and extrapancreatic effects.
Hartman I; Rojas E; Rodríguez-Molina D
Am J Ther; 2013; 20(4):384-93. PubMed ID: 23459193
[TBL] [Abstract][Full Text] [Related]
6. Therapies for the treatment of type 2 diabetes mellitus based on incretin action.
Gallwitz B
Minerva Endocrinol; 2006 Jun; 31(2):133-47. PubMed ID: 16682937
[TBL] [Abstract][Full Text] [Related]
7. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
Neumiller JJ
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
[TBL] [Abstract][Full Text] [Related]
8. Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
Hansen KB; Knop FK; Holst JJ; Vilsbøll T
Int J Clin Pract; 2009 Aug; 63(8):1154-60. PubMed ID: 19624785
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide (Victoza) for type 2 diabetes.
Med Lett Drugs Ther; 2010 Apr; 52(1335):25-7. PubMed ID: 20360660
[TBL] [Abstract][Full Text] [Related]
10. The effects of glucagon-like peptide-1 on the beta cell.
Vilsbøll T
Diabetes Obes Metab; 2009 Dec; 11 Suppl 3():11-8. PubMed ID: 19878257
[TBL] [Abstract][Full Text] [Related]
11. Emerging GLP-1 receptor agonists.
Lund A; Knop FK; Vilsbøll T
Expert Opin Emerg Drugs; 2011 Dec; 16(4):607-18. PubMed ID: 21905764
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.
Nauck MA; Meier JJ
Regul Pept; 2005 Jun; 128(2):135-48. PubMed ID: 15780433
[TBL] [Abstract][Full Text] [Related]
13. On-target effects of GLP-1 receptor agonists on thyroid C-cells in rats and mice.
Rosol TJ
Toxicol Pathol; 2013 Feb; 41(2):303-9. PubMed ID: 23471186
[TBL] [Abstract][Full Text] [Related]
14. [GLP-1 mimetics in clinical studies. Treatment by activation of the GLP-1 receptor].
Ritzel RA
Pharm Unserer Zeit; 2010 Mar; 39(2):120-5. PubMed ID: 20196040
[No Abstract] [Full Text] [Related]
15. Non-glycaemic effects mediated via GLP-1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide.
Vilsbøll T; Garber AJ
Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():41-9. PubMed ID: 22405268
[TBL] [Abstract][Full Text] [Related]
16. Minireview: update on incretin biology: focus on glucagon-like peptide-1.
Brubaker PL
Endocrinology; 2010 May; 151(5):1984-9. PubMed ID: 20305008
[TBL] [Abstract][Full Text] [Related]
17. Next-generation GLP-1 therapy: an introduction to liraglutide.
Repas T
Postgrad Med; 2011 Sep; 123(5):239-47. PubMed ID: 21904107
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of antidiabetic actions of GLP-1 in patients with diabetes.
Vilsbøll T; Holst JJ; Knop FK
Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):453-62. PubMed ID: 19748063
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 receptor agonists today.
Marre M; Penfornis A
Diabetes Res Clin Pract; 2011 Sep; 93(3):317-27. PubMed ID: 21767888
[TBL] [Abstract][Full Text] [Related]
20. An overview of the pharmacokinetics, efficacy and safety of liraglutide.
Bode B
Diabetes Res Clin Pract; 2012 Jul; 97(1):27-42. PubMed ID: 22245694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
